Shares of Abingdon Health Plc (LON:ABDX – Get Free Report) shot up 4.8% during trading on Thursday . The stock traded as high as GBX 11 and last traded at GBX 11. 81,049 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 238,041 shares. The stock had previously closed at GBX 10.50.
Abingdon Health Price Performance
The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The business’s 50-day moving average is GBX 10.45 and its two-hundred day moving average is GBX 10.13. The company has a market capitalization of £27.80 million, a P/E ratio of -13.58 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Further Reading
- Five stocks we like better than Abingdon Health
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
